Welcome to LookChem.com Sign In|Join Free

CAS

  • or

882033-33-2

Post Buying Request

882033-33-2 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

882033-33-2 Usage

Structure

A heterocyclic organic compound containing a pyridine ring fused to a pyrrole ring.

Substitution

Methoxy groups attached at the 5th and 6th positions.

Potential applications

Medicinal chemistry, particularly in the development of new pharmaceuticals.

Importance

The pyrrolopyridine core makes it a valuable building block for the synthesis of biologically active molecules and pharmaceutical drugs.

Uniqueness

Unique chemical structure and properties make it an important research target for drug discovery and development.

Check Digit Verification of cas no

The CAS Registry Mumber 882033-33-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,8,2,0,3 and 3 respectively; the second part has 2 digits, 3 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 882033-33:
(8*8)+(7*8)+(6*2)+(5*0)+(4*3)+(3*3)+(2*3)+(1*3)=162
162 % 10 = 2
So 882033-33-2 is a valid CAS Registry Number.

882033-33-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 5,6-dimethoxy-1H-pyrrolo[3,2-b]pyridine

1.2 Other means of identification

Product number -
Other names 5,6-DIMETHOXY-4-AZAINDOLE

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:882033-33-2 SDS

882033-33-2Relevant articles and documents

Design of potent IGF1-R inhibitors related to bis-azaindoles

Nemecek, Conception,Metz, William A.,Wentzler, Sylvie,Ding, Fa-Xiang,Venot, Corinne,Souaille, Catherine,Dagallier, Anne,Maignan, Sebastien,Guilloteau, Jean-Pierre,Bernard, Francois,Henry, Alain,Grapinet, Sandrine,Lesuisse, Dominique

, p. 100 - 106 (2011/03/19)

From an azaindole lead, identified in high throughput screen, a series of potent bis-azaindole inhibitors of IGF1-R have been synthesized using rational drug design and SAR based on a in silico binding mode hypothesis. Although the resulting compounds produced the expected improved potency, the model was not validated by the co-crystallization experiments with IGF1-R.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 882033-33-2